Hence, PRR11 serves as a reliable prognostic and diagnostic indicator in TSCC, NSCLC, BRCA, GC, HCC, HCCA, Pancreatic cancer and Ovarian cancer. This evidence concerns the gene PRR11 and familial pancreatic carcinoma.